Skip to content
healthcare.dev

Mucus Relief Maximum Strength 1200 mg

NDC 53041-191, Guaifenesin, tablet, extended release, from Guardian Drug Company.

Product NDC
53041-191
Status
Listed
Labeler
Guardian Drug Company
Dosage form
TABLET, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
ANDA
Application
ANDA209215
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/53041-191 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • GUAIFENESIN1200 mg/1

Pharmacologic classes

Decreased Respiratory Secretion Viscosity [PE]; Expectorant [EPC]; Increased Respiratory Secretions [PE]

Package NDCNDC-11Package
53041-191-375304101913728 TABLET, EXTENDED RELEASE in 1 BOTTLE (53041-191-37)
53041-191-48530410191484 BLISTER PACK in 1 CARTON (53041-191-48) / 7 TABLET, EXTENDED RELEASE in 1 BLISTER PACK
53041-191-58530410191582 BLISTER PACK in 1 CARTON (53041-191-58) / 7 TABLET, EXTENDED RELEASE in 1 BLISTER PACK
53041-191-625304101916270 TABLET, EXTENDED RELEASE in 1 BOTTLE (53041-191-62)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 53041-191 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/53041-191 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 53041-191. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.